# 18F-DTBZ for l Diagnosis of Parkinson's Disease and Monitoring the Severity of Disease by VMAT2 PET Imaging

> **NCT01283347** · PHASE2 · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 100 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** 18F-DTBZ

## Key facts

- **NCT ID:** NCT01283347
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2012-04
- **Final completion:** 2012-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2012-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01283347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01283347, "18F-DTBZ for l Diagnosis of Parkinson's Disease and Monitoring the Severity of Disease by VMAT2 PET Imaging". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01283347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
